AlgiPharma features in CFF drug development pipeline
AlgiPharma now features on the Cystic Fibrosis Foundation (CFF) drug development pipeline
Entries by Philip Rye
AlgiPharma signs new license agreement with NTNU
AlgiPharma secures new license agreement with NTNU for exclusive global rights.
AlgiPharma granted Orphan Drug designation by FDA
AlgiPharma granted Orphan Drug designation by FDA
